Magnetic Resonance Imaging (MRI) is an advanced imaging technology that is used to diagnose various medical conditions. It uses strong magnetic fields and radio waves to create detailed images of the organs and tissues in the body, and is used to assess and diagnose conditions relating to the brain and heart, as well as for cancer screenings and diagnostics. MRI works by first placing the patient in a powerful magnetic field, which causes the protons inside their body to align. Radio waves are then sent through the body, altering the alignment of the protons. When the radio waves cease, the protons return to their original position and release a tiny burst of energy, which is then detected by the MRI equipment and used to create an image. One of the main advantages of MRI is its high resolution imaging capability, which enables doctors to view detailed images of organs and tissues. It also avoids exposing the patient to radiation, making it safer than traditional X-rays. Additionally, MRI exams can typically be completed within 30 minutes, eliminating the need for long imaging sessions. Another advantage of MRI is that it can be used to assess biopsies and tissue samples. It uses a combination of hydrogen-based imaging and tissue sample analysis to detect tumors, cancer, and other abnormalities. Overall, MRI is a safe and effective imaging technique that provides high-quality images of the body and can be used to detect a wide range of medical conditions. It is a valuable tool for doctors, and can yield valuable insights into a patient’s health.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom